REWARDING, NOT CHALLENGING: GENESIS CHIEF CREATIVE OFFICER ON LUXURY HIGHPERFORMANCE PHILOSOPHY
Frankfurt, Germany, 16 October 2025: When Luc Donckerwolke, Chief Creative Officer of…
EyePoint Announces Proposed Public Offering of Common Stock
October 14, 2025 16:35 ET | Source: EyePoint Pharmaceuticals, Inc. WATERTOWN, Mass.,…
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre”…
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
October 10, 2025 17:16 ET | Source: Bluejay Diagnostics, Inc. ACTON, Mass.,…
Idorsia successfully completes an upsized offering of shares funding the company to overall profitability
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION,…
C1 Fund Inc. Announces Equity Purchase in Ripple, Leading Enterprise Blockchain Solutions Provider
PALO ALTO, Calif.--(BUSINESS WIRE)--C1 Fund Inc. (NYSE: CFND) (“C1 Fund” or the…
Diginex Announces Completion of Acquisition of Matter DK ApS, Strengthening Diginexs AI-driven ESG Data and Analytics Leadership
October 03, 2025 16:05 ET | Source: Diginex Limited LONDON, Oct. 03,…
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
NextGen Digital Platforms Inc. Responds to OTC Markets Request on Recent Promotional Activity
October 02, 2025 21:00 ET | Source: NextGen Digital Platforms Inc. Vancouver,…